Application YC di Abalone Bio

Winter 2020Active

Abalone Bio ha partecipato a Y Combinator nel batch Winter 2020 come azienda Healthcare. Sotto: cosa fa l'azienda, chi l'ha fondata e la sua application a YC, ricostruita domanda per domanda nel form reale di YC.

Batch YC: Winter 2020
Settore: HealthcareDrug Discovery and Delivery
Dimensione team: 14
Stato: Active
Lanciata: 2020

Founder

Richard YuFounder
Gustavo PesceFounder

Cosa fa Abalone Bio

Abalone Bio is tackling challenging undrugged targets underlying diseases affecting millions, focusing first cell-specific antibody drugs to treat obesity and metabolic disease without the GI side effects that cause 25% of GLP-1 drug patients to quit after 1 year. + High throughput experimental measurement uniquely leverages AI/ML: We’ve engineered cells to measure antibodies for pharmacological activity, not just structure or binding like others, 100 million at a time, 100X+ the throughput of others. With our large, proprietary activity datasets, we uniquely leverage ML to both unlock the discovery of rare hits and generate optimized hits for challenging targets, starting with G-protein coupled receptors (GPCRs) + Proven success: We have developed antibody agonists (activators) for 2 out of the 8 G-protein coupled receptors ever drugged by biotech. + Pharma traction: We’ve secured 3 partnerships with $3M in revenue and $125M in downstream value. + Externally validated science: We’ve been awarded $7M in non-dilutive grant funding for platform and program development.

Application YC di Abalone Bio, ricostruita

Domanda per Y Combinator

Abalone Bio, batch Winter 2020. Le vere domande del form, risposte da dati pubblici.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Abalone Bio

Describe what your company does in 50 characters or less.

We create activating antibodies to treat diseases others can't.

What is your company going to make? Please describe your product and what it does or will do.

We build a platform that combines high-throughput experimental antibody screening with machine learning to discover activating antibodies targeting cell-specific receptors. Our product enables discovery and optimization of rare antibody hits against challenging targets like GPCRs, starting in obesity and metabolic diseases, focusing on safety and efficacy beyond current drugs.

Where do you live now, and where would the company be based after YC?

We live in San Francisco, CA, and the company is based here.

Explain your decision regarding location.

San Francisco is a hub for biotech and AI talent, which is critical for our platform combining synthetic biology and machine learning. Being in SF keeps us close to partners and investors focused on healthcare innovation.

21 risposte in più nell'application completa

Founders, Progress, Idea, Equity, Curious, Batch Preference sono nella versione completa. Crea un account gratuito per aprirla in YC Insights, accanto a ogni altro batch YC.

Vedi domanda completa

Domande Frequenti

Questa è l'application YC reale di Abalone Bio?

No. Y Combinator mantiene private le application inviate. Questa è una ricostruzione: le domande del form YC reale, a cui si è risposto usando i dati pubblici di Abalone Bio (note di lancio, background dei founder, descrizione del prodotto). Mostra come un'azienda come Abalone Bio si presenterebbe a YC, non il testo che hanno inviato.

A quale batch YC apparteneva Abalone Bio?

Abalone Bio apparteneva al batch Winter 2020 di Y Combinator.

Chi ha fondato Abalone Bio?

Abalone Bio è stato fondato da Richard Yu, Gustavo Pesce.

Cosa fa Abalone Bio?

We create activating antibodies to treat diseases others can’t.

Come leggo la ricostruzione completa della application?

Crea un account Round Funded gratuito. La versione completa di 26 risposte della application di Abalone Bio, e di ogni altro batch YC, è in YC Insights.